Jul. 13 at 3:43 AM
Our records, which are not authoritative, note the 730% gain in
$INKT is a record for all bios (excluding nano-caps) going back to 1/1/2022. This is not investment advice. INKT is developing what could be a game changing cancer therapy but, caution should be exercised because, as we understand the matter, the gain was the result of publishing the result of one patient (but it is a heck of a result).
By comparison,
$VTGN saw like gains after publishing Phase 3 data for a social anxiety therapy.
Of the 21 bios like INKT that saw 200%+ gains in 1 day, 5 traded higher 5 days later. 11 of the 21 trade higher today (roughly 50/50).
$PROK was not 5 days ago. We track these data points manually so of course we could have missed one.
$SRRK has a 9/22/2025 PDUFA date.
We believe
$MDGL is a B/O candidate but remember there are significant dilutive shares (or were as of 3/31/2025).
